Certolizumab Pegol Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: CAD1C46D63C2EN
Market Monitor Global

Abstracts

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

This report contains market size and forecasts of Certolizumab Pegol in Global, including the following market information:

Global Certolizumab Pegol Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Certolizumab Pegol market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single-dose vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Certolizumab Pegol include UCB. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Certolizumab Pegol companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Certolizumab Pegol Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Certolizumab Pegol Market Segment Percentages, by Type, 2021 (%)

• Single-dose vial
• Single-dose prefilled syringe

Global Certolizumab Pegol Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Certolizumab Pegol Market Segment Percentages, by Application, 2021 (%)

• Crohn’s disease
• Active rheumatoid arthritis
• Active psoriatic arthritis

Global Certolizumab Pegol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Certolizumab Pegol Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Certolizumab Pegol revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Certolizumab Pegol revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• UCB

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Certolizumab Pegol Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Certolizumab Pegol Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CERTOLIZUMAB PEGOL OVERALL MARKET SIZE

2.1 Global Certolizumab Pegol Market Size: 2021 VS 2028
2.2 Global Certolizumab Pegol Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Certolizumab Pegol Players in Global Market
3.2 Top Global Certolizumab Pegol Companies Ranked by Revenue
3.3 Global Certolizumab Pegol Revenue by Companies
3.4 Top 3 and Top 5 Certolizumab Pegol Companies in Global Market, by Revenue in 2021
3.5 Global Companies Certolizumab Pegol Product Type
3.6 Tier 1, Tier 2 and Tier 3 Certolizumab Pegol Players in Global Market
  3.6.1 List of Global Tier 1 Certolizumab Pegol Companies
  3.6.2 List of Global Tier 2 and Tier 3 Certolizumab Pegol Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Certolizumab Pegol Market Size Markets, 2021 & 2028
  4.1.2 Single-dose vial
  4.1.3 Single-dose prefilled syringe
4.2 By Type - Global Certolizumab Pegol Revenue & Forecasts
  4.2.1 By Type - Global Certolizumab Pegol Revenue, 2017-2022
  4.2.2 By Type - Global Certolizumab Pegol Revenue, 2023-2028
  4.2.3 By Type - Global Certolizumab Pegol Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Certolizumab Pegol Market Size, 2021 & 2028
  5.1.2 Crohn’s disease
  5.1.3 Active rheumatoid arthritis
  5.1.4 Active psoriatic arthritis
5.2 By Application - Global Certolizumab Pegol Revenue & Forecasts
  5.2.1 By Application - Global Certolizumab Pegol Revenue, 2017-2022
  5.2.2 By Application - Global Certolizumab Pegol Revenue, 2023-2028
  5.2.3 By Application - Global Certolizumab Pegol Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Certolizumab Pegol Market Size, 2021 & 2028
6.2 By Region - Global Certolizumab Pegol Revenue & Forecasts
  6.2.1 By Region - Global Certolizumab Pegol Revenue, 2017-2022
  6.2.2 By Region - Global Certolizumab Pegol Revenue, 2023-2028
  6.2.3 By Region - Global Certolizumab Pegol Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Certolizumab Pegol Revenue, 2017-2028
  6.3.2 US Certolizumab Pegol Market Size, 2017-2028
  6.3.3 Canada Certolizumab Pegol Market Size, 2017-2028
  6.3.4 Mexico Certolizumab Pegol Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Certolizumab Pegol Revenue, 2017-2028
  6.4.2 Germany Certolizumab Pegol Market Size, 2017-2028
  6.4.3 France Certolizumab Pegol Market Size, 2017-2028
  6.4.4 U.K. Certolizumab Pegol Market Size, 2017-2028
  6.4.5 Italy Certolizumab Pegol Market Size, 2017-2028
  6.4.6 Russia Certolizumab Pegol Market Size, 2017-2028
  6.4.7 Nordic Countries Certolizumab Pegol Market Size, 2017-2028
  6.4.8 Benelux Certolizumab Pegol Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Certolizumab Pegol Revenue, 2017-2028
  6.5.2 China Certolizumab Pegol Market Size, 2017-2028
  6.5.3 Japan Certolizumab Pegol Market Size, 2017-2028
  6.5.4 South Korea Certolizumab Pegol Market Size, 2017-2028
  6.5.5 Southeast Asia Certolizumab Pegol Market Size, 2017-2028
  6.5.6 India Certolizumab Pegol Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Certolizumab Pegol Revenue, 2017-2028
  6.6.2 Brazil Certolizumab Pegol Market Size, 2017-2028
  6.6.3 Argentina Certolizumab Pegol Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Certolizumab Pegol Revenue, 2017-2028
  6.7.2 Turkey Certolizumab Pegol Market Size, 2017-2028
  6.7.3 Israel Certolizumab Pegol Market Size, 2017-2028
  6.7.4 Saudi Arabia Certolizumab Pegol Market Size, 2017-2028
  6.7.5 UAE Certolizumab Pegol Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 UCB
  7.1.1 UCB Corporate Summary
  7.1.2 UCB Business Overview
  7.1.3 UCB Certolizumab Pegol Major Product Offerings
  7.1.4 UCB Certolizumab Pegol Revenue in Global Market (2017-2022)
  7.1.5 UCB Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Certolizumab Pegol Market Opportunities & Trends in Global Market
Table 2. Certolizumab Pegol Market Drivers in Global Market
Table 3. Certolizumab Pegol Market Restraints in Global Market
Table 4. Key Players of Certolizumab Pegol in Global Market
Table 5. Top Certolizumab Pegol Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Certolizumab Pegol Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Certolizumab Pegol Revenue Share by Companies, 2017-2022
Table 8. Global Companies Certolizumab Pegol Product Type
Table 9. List of Global Tier 1 Certolizumab Pegol Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Certolizumab Pegol Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Certolizumab Pegol Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Certolizumab Pegol Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Certolizumab Pegol Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Certolizumab Pegol Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Certolizumab Pegol Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Certolizumab Pegol Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Certolizumab Pegol Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Certolizumab Pegol Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Certolizumab Pegol Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Certolizumab Pegol Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Certolizumab Pegol Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Certolizumab Pegol Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Certolizumab Pegol Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Certolizumab Pegol Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Certolizumab Pegol Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Certolizumab Pegol Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Certolizumab Pegol Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Certolizumab Pegol Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Certolizumab Pegol Revenue, (US$, Mn), 2023-2028
Table 30. UCB Corporate Summary
Table 31. UCB Certolizumab Pegol Product Offerings
Table 32. UCB Certolizumab Pegol Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Certolizumab Pegol Segment by Type in 2021
Figure 2. Certolizumab Pegol Segment by Application in 2021
Figure 3. Global Certolizumab Pegol Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Certolizumab Pegol Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Certolizumab Pegol Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Certolizumab Pegol Revenue in 2021
Figure 8. By Type - Global Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 9. By Application - Global Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 10. By Region - Global Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 11. By Country - North America Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 12. US Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 16. Germany Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 17. France Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 24. China Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 28. India Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 30. Brazil Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Certolizumab Pegol Revenue Market Share, 2017-2028
Figure 33. Turkey Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Certolizumab Pegol Revenue, (US$, Mn), 2017-2028
Figure 37. UCB Certolizumab Pegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)